Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Cipla appoints Dr Raju...

    Cipla appoints Dr Raju Mistry as Global Chief People Officer

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2019-04-23T09:15:03+05:30  |  Updated On 14 Aug 2021 6:20 AM GMT

    In her role at Cipla, Raju Mistry will oversee Human Resources, and Administration and Facilities Management. She will be a member of the Management Council of Cipla and will report to Umang Vohra, Managing Director & Global Chief Executive Officer.


    Mumbai: Cipla Limited has announced the appointment of Dr Raju Mistry as President and Global Chief People Officer (GCPO) of Cipla.


    Raju is an accomplished and veteran Human Resources (HR) leader with over 27 years of global experience across diverse sectors such as Chemicals, Pharma, FMCG, IT, Engineering and Textiles.


    Read Also: Cipla acquires 30 per cent stake in Brandmed for Rs 32 crore


    Prior to joining Cipla, Raju was Chief Human Resources Officer (CHRO) at Jubilant Life Sciences Ltd. For 13 years before that, Raju led the talent, employer brand and leadership programmes of the Aditya Birla Group, and was CHRO of Grasim's Pulp and Fibre business. She has previously worked with Tata Sons, Colgate Palmolive, Siemens, and Mastech Corporation, Canada.


    In her role at Cipla, Raju will oversee Human Resources, and Administration and Facilities Management. She will be a member of the Management Council of Cipla and will report to Umang Vohra, Managing Director & Global Chief Executive Officer.


    Read Also: Cipla, Pulmatrix join hands to co-develop Pulmazole for treating asthma


    Commenting on the appointment, Umang Vohra, Managing Director & Global Chief Executive Officer of Cipla said: "We are delighted to welcome Raju to the Cipla family. In the last few years, Cipla has successfully worked towards strengthening its core, reiterating its values and focusing on building a future-ready organisation. Raju brings with her the experience to continue the journey and help us reach new milestones."


    Established in 1935, Cipla is a global pharmaceutical company focused on agile and sustainable growth, complex generics, and deepening portfolio in markets of India, South Africa, North America, and key regulated and emerging markets. The firm is strengthened in the respiratory, anti-retroviral, urology, cardiology and CNS segments.

    Aditya Birla Group Chief Human Resources Officer CHRO Cipla Colgate Palmolive Dr Raju Mistry FMCG Global Chief People Officer cipla Jubilant Life Sciences Mastech Corporation canada Mumbai pharma pharma news Raju Mistry Siemens Umang Vohra 

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier

      This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:

      Search only trustworthy HONcode health websites:

      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

      © 2020 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      X